US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
GB8609537D0
(en)
*
|
1986-04-18 |
1986-05-21 |
Ici Plc |
Polyesters
|
DE3720806C2
(de)
*
|
1986-07-03 |
1997-08-21 |
Clariant Finance Bvi Ltd |
Verwendung eines Stabilisators in Peroxydbleichverfahren
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3641692A1
(de)
*
|
1986-12-06 |
1988-06-09 |
Boehringer Ingelheim Kg |
Katalysatorfreie resorbierbare homopolymere und copolymere
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
AU634723B2
(en)
*
|
1988-08-08 |
1993-03-04 |
Biopak Technology, Ltd. |
Degradable thermoplastic from lactides
|
US5180765A
(en)
*
|
1988-08-08 |
1993-01-19 |
Biopak Technology, Ltd. |
Biodegradable packaging thermoplastics from lactides
|
BR8907604A
(pt)
*
|
1988-08-08 |
1991-07-30 |
Battelle Memorial Institute |
Composicao ambientalmente biodegradavel,processo para produzir a mesma e processo para tornar uma composicao de polimero termoplastico ambientalmente biodegradavel
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5424346A
(en)
*
|
1988-08-08 |
1995-06-13 |
Ecopol, Llc |
Biodegradable replacement of crystal polystyrene
|
US5250584A
(en)
*
|
1988-08-31 |
1993-10-05 |
G-C Dental Industrial Corp. |
Periodontium-regenerative materials
|
JP2714454B2
(ja)
*
|
1988-11-07 |
1998-02-16 |
三井東圧化学株式会社 |
生体吸収性ポリエステルの製造方法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
DE4005415C2
(de)
*
|
1990-02-21 |
1996-04-11 |
Boehringer Ingelheim Kg |
Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
MY108621A
(en)
*
|
1990-08-01 |
1996-10-31 |
Novartis Ag |
Polylactide preparation and purification
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
NO302481B1
(no)
|
1990-10-16 |
1998-03-09 |
Takeda Chemical Industries Ltd |
Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
|
IT1249045B
(it)
*
|
1991-02-21 |
1995-02-11 |
Himont Inc |
Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5294469A
(en)
*
|
1992-06-17 |
1994-03-15 |
Mitsui Toatsu Chemicals, Incorporated |
Industrial woven fabric and composite sheet comprising same
|
US5758053A
(en)
*
|
1992-07-22 |
1998-05-26 |
Hitachi, Ltd. |
Fault handling and recovery for system having plural processors
|
WO1994008078A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Cargill, Incorporated |
A melt-stable lactide polymer fabric and process for manufacture thereof
|
AU5296393A
(en)
*
|
1992-10-02 |
1994-04-26 |
Cargill Incorporated |
Paper having a melt-stable lactide polymer coating and process for manufacture thereof
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
US6005068A
(en)
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
US5643595A
(en)
*
|
1992-11-24 |
1997-07-01 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
ATE288270T1
(de)
*
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
EP0789045B1
(de)
*
|
1995-08-29 |
2001-01-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Verfahren zur herstellung von polyhydroxycarbonsäure
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
WO1997031049A1
(fr)
*
|
1996-02-23 |
1997-08-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede d'elaboration d'acide polyhydroxycarboxylique
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6126919A
(en)
*
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
ES2359973T3
(es)
*
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
US6217844B1
(en)
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
ATE293652T1
(de)
*
|
1999-12-10 |
2005-05-15 |
Equipolymers Gmbh |
Katalysatorsysteme für polykondensationsreaktionen
|
US6960626B2
(en)
*
|
2000-01-21 |
2005-11-01 |
Cyclics Corporation |
Intimate physical mixtures containing macrocyclic polyester oligomer and filler
|
ES2577389T3
(es)
*
|
2000-08-07 |
2016-07-14 |
Wako Pure Chemical Industries, Ltd. |
Polímero de ácido láctico y procedimiento para su producción
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
DE60135759D1
(de)
*
|
2000-08-16 |
2008-10-23 |
Tyco Healthcare |
Absorbierendes polymerharz mit hoher konsistenz
|
US7767781B2
(en)
|
2000-09-01 |
2010-08-03 |
Cyclics Corporation |
Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
|
US7750109B2
(en)
|
2000-09-01 |
2010-07-06 |
Cyclics Corporation |
Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
|
AU2002324447B2
(en)
|
2001-06-22 |
2006-06-29 |
Durect Corporation |
Zero-order prolonged release coaxial implants
|
US7071291B2
(en)
|
2001-06-27 |
2006-07-04 |
Cyclics Corporation |
Isolation, formulation and shaping of macrocyclic oligoesters
|
AR034641A1
(es)
*
|
2001-06-29 |
2004-03-03 |
Takeda Pharmaceutical |
Composicion de liberacion controlada y metodo para producirla
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US6849600B2
(en)
*
|
2002-03-25 |
2005-02-01 |
The Regents Of The University Of California, Berkeley |
Corticotropin-releasing hormone analogs
|
WO2004029129A1
(ja)
*
|
2002-09-24 |
2004-04-08 |
Asahi Kasei Chemicals Corporation |
グリコール酸共重合体及びその製造方法
|
EP1440992A1
(de)
*
|
2003-01-21 |
2004-07-28 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
CA2533314C
(en)
|
2003-07-18 |
2013-07-09 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
DE112005000965T5
(de)
*
|
2004-04-28 |
2007-03-22 |
Keio University |
Depolymerisationsverfahren für Polymere mit Esterbindung in der Hauptkette und Verfahren zur Herstellung von Polymeren mit Esterbindung in der Hauptkette aus dem Depolymerisationsprodukt
|
EP1761178B1
(de)
*
|
2004-05-21 |
2010-12-08 |
Micro Therapeutics, Inc. |
Mit biologischen oder biologisch abbaubaren oder synthetischen polymeren oder fasern umschlungene metallspulen zur embolisierung einer körperhöhle
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
WO2006032291A1
(de)
|
2004-09-22 |
2006-03-30 |
Dendron Gmbh |
Vorrichtung zur implantation von mikrowendeln
|
DE102005019782A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Dendron Gmbh |
Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
|
EP1716847B1
(de)
*
|
2005-04-28 |
2008-01-02 |
Nipro Corporation |
Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
WO2007067964A2
(en)
*
|
2005-12-08 |
2007-06-14 |
Nastech Pharmaceutical Company Inc. |
Mucosal delivery of stabilized formulations of exendin
|
EP3029461B1
(de)
|
2006-11-01 |
2017-12-20 |
Ventana Medical Systems, Inc. |
Haptene, haptenkonjugate, zusammensetzungen daraus und verfahren für ihre herstellung und verwendung
|
TWI481424B
(zh)
|
2006-12-18 |
2015-04-21 |
Takeda Pharmaceutical |
緩釋性組成物及其製法
|
KR20100015520A
(ko)
|
2007-03-13 |
2010-02-12 |
마이크로 테라퓨틱스 인코포레이티드 |
코일과 펴짐방지 부재를 포함하는 임플란트
|
WO2010009451A2
(en)
|
2008-07-17 |
2010-01-21 |
Merial Limited |
Long-acting injectable analgesic formulations for animals
|
WO2010047674A1
(en)
|
2008-10-20 |
2010-04-29 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
|
CA2740970A1
(en)
|
2008-10-21 |
2010-04-29 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
CN101445595B
(zh)
*
|
2008-12-26 |
2011-01-19 |
上海新上化高分子材料有限公司 |
聚乙丙交酯及其制备方法和应用
|
US9365612B2
(en)
|
2010-01-29 |
2016-06-14 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Caspase inhibitors
|
WO2011127388A2
(en)
|
2010-04-08 |
2011-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inverse agonists and neutral antagonists for the tsh receptor
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
EP2685985B1
(de)
|
2011-03-17 |
2016-08-31 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Verfahren zur behandlung von leukämie und erkrankungen durch cbf- und runx1-proteine
|
CN102295765B
(zh)
*
|
2011-06-30 |
2012-11-28 |
南京大学 |
生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
|
CN102329269B
(zh)
*
|
2011-06-30 |
2013-07-17 |
南京大学 |
仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
EP2802565A4
(de)
|
2012-01-13 |
2015-07-08 |
Univ Oregon Health & Science |
Verbindungen, zusammensetzungen und zugehörige verfahren mit 3-aryl-chinolinen
|
PL2858975T3
(pl)
|
2012-06-08 |
2019-10-31 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Inhibitory fbxo3
|
WO2014078309A1
(en)
|
2012-11-13 |
2014-05-22 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Cannabinoid receptor mediating compounds
|
WO2014093702A1
(en)
|
2012-12-12 |
2014-06-19 |
The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Hiv therapeutics and methods of making and using same
|
EP2996691A1
(de)
|
2013-05-16 |
2016-03-23 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Verbindungen zur hemmung medikamentenresistenter stämme der hiv-1-integrase
|
JP6564380B2
(ja)
|
2013-09-20 |
2019-08-21 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
前立腺癌を治療するための化合物
|
US10398772B2
(en)
|
2014-01-08 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
|
CA2948349C
(en)
|
2014-05-09 |
2023-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pyrazole derivatives and their use as cannabinoid receptor mediators
|
CA2959347C
(en)
|
2014-08-25 |
2023-03-07 |
Salk Institute For Biological Studies |
Ulk1 inhibitors and methods using same
|
US10400015B2
(en)
|
2014-09-04 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant HIV-1 envelope proteins and their use
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
WO2016103238A1
(en)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus f proteins and their use
|
US10196372B2
(en)
|
2015-01-05 |
2019-02-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
MYC G-quadruplex stabilizing small molecules and their use
|
SG11201706729SA
(en)
|
2015-02-20 |
2017-09-28 |
Univ Oregon Health & Science |
Derivatives of sobetirome
|
US20180273485A1
(en)
|
2015-06-04 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Cannabinoid receptor mediating compounds
|
US10799580B2
(en)
|
2015-09-09 |
2020-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Expression vector delivery system and use thereof for inducing an immune response
|
WO2017151802A1
(en)
|
2016-03-04 |
2017-09-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor mediating compounds
|
SI3457851T1
(sl)
|
2016-05-18 |
2022-04-29 |
Oregon Health & Science University |
Derivati sobetiroma
|
US20190255079A1
(en)
|
2016-06-16 |
2019-08-22 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
WO2018109220A2
(en)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
WO2019046748A1
(en)
|
2017-08-31 |
2019-03-07 |
Evonik Corporation |
ENHANCED RESORBABLE POLYMER PURIFICATION METHOD
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
BR112020018832A2
(pt)
|
2018-03-29 |
2021-02-09 |
Elex Biotech, Inc. |
compostos para o tratamento de arritimias cardíacas e insuficiência cardíaca
|
JP2022502378A
(ja)
|
2018-09-25 |
2022-01-11 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
2’−ハロゲン化−4’−チオ−2’−デオキシ−5−アザシチジンアナログおよびその使用
|
JP2022513449A
(ja)
|
2018-12-12 |
2022-02-08 |
オートバーン セラピューティクス,インク. |
新規な甲状腺模倣物
|
CA3130371A1
(en)
|
2019-03-01 |
2020-09-10 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
WO2020185695A1
(en)
|
2019-03-11 |
2020-09-17 |
Oregon State University |
Analogues and derivatives of cephalotaxine and methods for making and using the compounds
|
CA3222837A1
(en)
|
2021-06-09 |
2022-12-15 |
John S. Schneekloth |
Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|